Health Technology, Healthcare Analytics
businesswire | July 28, 2023
AscellaHealth, a global healthcare and specialty pharmacy solutions organization, today released its Q2 2023 Specialty & Rare Pipeline Digest™, the industry’s most comprehensive resource on new, pending and projected Specialty and Rare Disease drug launches, and cell and gene therapies, biosimilars and generics. This complimentary, valuable source of industry information supports the specialty drug market needs of stakeholders and decision-makers including pharmaceutical manufacturers, payers and providers, with essential updates on products that are making an impact for millions of individuals living with or affected by rare disease or complex chronic conditions.
“As an industry-leading, global healthcare and specialty pharmacy solutions organization, my team researched, annotated and compiled these critically important updates, timely information, statistics and facts to support our clients and partners and other industry stakeholders,” says Andy Szczotka, PharmD, chief pharmacy officer, AscellaHealth.
Dea Belazi, president & CEO, AscellaHealth, adds, “We are proud to empower all market stakeholders with key data and insights that guide the industry. The dedicated work of pharmaceutical manufacturers to launch innovative therapies complemented by the efforts of payers and providers to ensure affordability and treatment availability are so commendable.”
AscellaHealth provides end-to-end, customized solutions to all industry stakeholders, namely patients, life sciences manufacturers, payers and providers to improve medication access, optimize clinical outcomes and enhance the patient journey. Services include:
Pre-Commercialization & Market Access
Exclusive Distribution, Wholesale, and 3PL Services
International Specialty Pharmacy Fulfillment including Limited Distribution Drugs
Comprehensive HUB and Patient Support Services
Custom Compliance and Persistency Programs
Streamlined Prior Authorizations
Technology-based Patient Engagement
Integrated Copay and Financial Assistance Programs
Real-time Rx Data and Analytics
Specialty Pharmacy & Medical Benefit Management
About AscellaHealth LLC
AscellaHealth, a global Healthcare & Specialty Pharmacy solutions organization, serving patients, life sciences manufacturers, payers and providers, offers a comprehensive portfolio of uniquely tailored, tech-enabled services supporting complex, chronic conditions or rare diseases that require specialty medications and/or cell and gene therapies. A recipient of numerous industry awards for innovation, and a NASP Strategic Channel Partner of the Year award winner, AscellaHealth’s best-in-class, patient-centric approach is built upon proprietary technology processes for novel programs and services to support the launch of specialty medications and proactively address multiple challenges, optimize clinical health outcomes, and improve quality of life for this patient population.
businesswire | August 24, 2023
Press Ganey, the renowned leader in transforming the Human Experience (HX) across the healthcare ecosystem of patient, employee, member, and consumer journeys, announced a strategic partnership with Ardent Health Services, a leading healthcare provider with 30 hospitals, more than 200 sites of care and 1,400 aligned providers across six states.
The two organizations aim to redefine the Human Experience of healthcare and accelerate the drive toward zero harm. Bolstered by a shared commitment to safety, quality, and patient experience, the partnership leverages Press Ganey's Human Experience platform to pioneer advancements across the continuum of care.
Ardent’s relationship with Press Ganey underscores their shared vision for a safer, more human-focused era of healthcare. Through this collaboration, Ardent will harness Press Ganey's industry-leading Human Experience platform, fostering a proactive and holistic approach to healthcare excellence and innovation.
“Ardent’s partnership with Press Ganey aligns with our commitment to caring for others and a culture of safety through our MissionZERO initiative,” said Marty Bonick, President and CEO of Ardent. “As part of our journey to become a highly reliable organization, we hold ourselves to the highest standard of patient care and recognize Press Ganey as a true partner in this endeavor. Together, we understand that the people we serve are at the center of all we do. That is the Human Experience."
Press Ganey's approach to patient experience and safety aligns seamlessly with Ardent's commitment to innovation and its MissionZERO imperative. Through the partnership, both organizations will push the envelope of healthcare transformation, leading the charge toward a future marked by exceptional patient outcomes and a culture of high reliability.
"We are honored to stand side by side with Ardent in their unwavering resolve to achieve MissionZERO. Our mutual dedication to advancing the Human Experience in healthcare is a powerful catalyst for positive transformation," said Patrick T. Ryan, Chairman and CEO of Press Ganey. "This partnership reinforces our firm belief that every patient deserves the highest level of care and safety, and an experience defined by compassion."
About Press Ganey
Press Ganey, the leading Human Experience (HX) healthcare performance improvement company, offers an integrated suite of solutions that address safety, clinical excellence, patient and member experience and workforce engagement. The company works with more than 41,000 healthcare facilities in its mission to reduce patient suffering and enhance caregiver resilience to improve the overall safety, quality, and experience of care. Press Ganey is a PG Forsta company.
About PG Forsta
PG Forsta provides the technology and expertise to help organizations get a deeper, more complete understanding of the experiences of their audiences. The company powers the HX (Human Experience) Platform—a comprehensive experience and research technology platform that breaks down the silos between CX (Customer Experience), Employee Experience (EX), Patient Experience (PX), and Market Research. PG Forsta serves a variety of industries, including healthcare, financial services, hospitality, market research, professional services, retail, and technology.
About Ardent Health Services
Ardent Health Services is a leading provider of healthcare in communities across the country. With a focus on consumer-friendly processes and investments in innovative services and technologies, Ardent is passionate about making healthcare better and easier to access. Through its subsidiaries, Ardent owns and operates 30 hospitals and 200+ sites of care with more than 1,400 aligned providers in six states. From newly constructed healthcare facilities and expanded services to lifesaving technology and outstanding opportunities for team members, Ardent is committed to providing the resources communities need to keep high quality healthcare close to home.
PRNewswire | June 30, 2023
Aido announced a transformative partnership with Ochsner Health, a large healthcare system headquartered in New Orleans, operating 46 hospitals and more than 370 health and urgent care centers across the Gulf South. This partnership unites the clinical excellence of Ochsner with the power of Aidoc's advanced AI solutions, creating an alliance that advances the way healthcare is delivered, experienced and optimized across Louisiana and the Gulf South region.
Ochsner has a proven track record as a leading adopter of emerging technologies and was an early adopter of integrating AI into patient care workflows. With the addition of Aidoc's clinical AI solutions and enterprise-wide AI platform, aiOS™, Ochsner is further empowering healthcare professionals and improving patient outcomes.
"In the ever-evolving healthcare landscape, our teams at Ochsner Health are dedicated to harnessing emerging technologies to achieve our goals. We seek to leverage new technologies to deliver optimal outcomes without disrupting existing care processes," says Denise Basow, MD, Executive Vice President and Chief Digital Officer at Ochsner. "Aidoc possesses a deep understanding of the crucial challenges in implementing new technologies and have a proven track record of real-world impact that drives improved patient outcomes."
Driven by a shared vision of advancing patient care, this partnership seeks to leverage emerging AI technology to drive tangible improvements across the healthcare landscape. Key objectives of this collaboration include
Elevating Patient Care: Ochsner aims to further enhance patient outcomes by harnessing enterprise-wide AI solutions that can ensure it delivers the highest quality of care and patient safety in all communities it serves.
Empowering Clinical Teams: The partnership is dedicated to supporting clinical teams by equipping them with advanced tools that alleviate stress and address burnout through automation and streamlined communication. Ochsner and Aidoc strive to enhance the capabilities of clinicians by supporting their decision-making processes.
Pioneering Solutions: As leaders in the digital health landscape, Ochsner and Aidoc are committed to pushing the boundaries of innovation. Together, both organizations will actively explore new solutions that address industry needs and challenges, setting a new standard for healthcare excellence benefiting patients in the Gulf South and beyond.
Advancing the Quadruple Aim: With a focus on improving patient outcomes, enhancing provider experiences, reducing costs and advancing population health, the partnership aligns closely with the quadruple aim in healthcare. With AI and digital health technologies, Ochsner continues its focus on creating a sustainable healthcare ecosystem that delivers value for all stakeholders.
"Embracing innovation is not just a choice but a responsibility, especially when it comes to patient care," stated Louis Jeansonne, MD, Chief Medical Information Officer at Ochsner. "By integrating AI into our clinical workflows, and leveraging the data within our EHR, we empower our team and pave the way for advancements that directly impact patient outcomes. This collaboration with Aidoc underscores our commitment to embracing cutting-edge technologies that have the power to reshape the healthcare landscape and provide better care to our patients."
Ochsner's enterprise agreement with Aidoc includes imaging AI algorithms that identify various suspected acute abnormalities in patient scans and enable cross-specialty teams to triage and coordinate care efficiently. Additionally, the agreement leverages Aidoc's proprietary aiOS™, a first-of-its-kind solution, helping facilities overcome challenges common to AI implementation, including integration with existing IT systems, the EHR, data management and reporting, while being flexible enough to grow and scale as patient care needs evolve.
There is growing recognition from health systems that an enterprise-wide AI platform that runs effectively in any clinical setting and activates numerous AI applications at once can provide better outcomes – both clinical and financial – than a single, pathology-based AI algorithm.
"Ochsner Health's unwavering dedication to innovation and trailblazing spirit is inspiring and is a testament to their continued pursuit of excellence," commented Elad Walach, CEO at Aidoc. "Our partnership is yet another proof point of how they embrace technology for true impact at the patient bedside. As we collaborate to integrate our enterprise-wide AI solutions, we are confident that our collective efforts will not only accelerate Ochsner's goals but also redefine the possibilities of patient care. Together, we will leverage the power of AI to drive transformative outcomes."
Aidoc is a pioneering force in clinical AI. We focus on aiding and empowering healthcare teams to optimize patient treatment, which results in improved economic value and clinical outcomes. Our clinically proven AI solutions eliminate silos, increase efficiencies and improve outcomes by delivering critical information when and where care teams need it leading to immediate collective action. Built on Aidoc's exclusive aiOS™, we analyze and aggregate medical data to enable care teams to operationalize the unexpected and work seamlessly with a continued focus on the patient. Used in more than 1,000 medical centers worldwide, Aidoc has the most FDA clearances (13) in clinical AI and its AI-based solutions cover 75 percent of patient populations, enabling physicians to make informed decisions based on real-time data. Aidoc AI is always on, running in the background to change the foreground. Visit Aidoc.com to see how we are connecting all points of care with always on AI.
About Ochsner Health
Ochsner Health is an integrated healthcare system with a mission to Serve, Heal, Lead, Educate and Innovate. Celebrating more than 80 years of service, it leads nationally in cancer care, cardiology, neurosciences, liver and kidney transplants and pediatrics, among other areas. Ochsner is consistently named both the top hospital and top children's hospital in Louisiana by U.S. News & World Report. The not-for-profit organization is inspiring healthier lives and stronger communities through its Healthy State by 2030 initiative, a bold and collaborative plan to realize a healthier Louisiana. Its focus is on preventing diseases and providing patient-centered care that is accessible, affordable, convenient and effective. Ochsner Health pioneers new treatments, deploys emerging technologies and performs groundbreaking research, including 4,000 patients enrolled in 685 clinical studies in 2022. It has more than 37,000 employees and over 4,700 employed and affiliated physicians in over 90 medical specialties and subspecialties. It operates 46 hospitals and more than 370 health and urgent care centers across Louisiana, Mississippi, Alabama and the Gulf South; and its cutting-edge Connected Health digital medicine program is caring for patients beyond its walls. In 2022, Ochsner Health treated more than 1.4 million people from every state and 62 countries.